Company: VRCA
Filing Date: 2025-11-14
Form Type: 8-K
Source: 0001193125-25-283078
Chunk: 0

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-11-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02      Results of Operations and Financial Condition.  

On November 14, 2025, Verrica Pharmaceuticals Inc. (the “ Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2025, as well as information regarding a conference call to discuss the financials and business updates. This press release has been furnished as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with General Instruction B.2. of Form 8-K, theinformation in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.